Phase II Trial Studies Effects of Semaglutide Medication in Patients with NASH
Newswise — Nonalcoholic steatohepatitis (NASH)-related cirrhosis can lead to serious liver-related outcomes. In a phase 2 trial, lead author Rohit Loomba, MD, University of California San Diego School of…
Read more Phase II Trial Studies Effects of Semaglutide Medication in Patients with NASH